Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration (CVVH), a Randomized Cross-over Trial Comparing Hemostasis Between Two Hemofiltration Rates

NCT00965328 is registered in ClinicalTrials.gov with Onze Lieve Vrouwe Gasthuis as lead sponsor.

NCT NCT00965328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00965328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration (CVVH), a Randomized Cross-over Trial Comparing Hemostasis Between Two Hemofiltration Rates
Lead sponsor
Onze Lieve Vrouwe Gasthuis
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2007
Completion date
May 31, 2008
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, kidney, multiple organ failure